Supplies of vincristine, a crucial drug in the treatment of several childhood cancers, are running critically low after one of the two manufacturers of the drug ceased production in July.
The U.S. Is Running Out Of A Critical Childhood Cancer Drug And There Is No Suitable Replacement.
